Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

8 results
Display

KSNM60 in Clinical Nuclear Oncology

Moon S, Cho Y, Choi J

Since the foundation of the Korean Society of Nuclear Medicine in 1961, clinical nuclear oncology has been a major part of clinical nuclear medicine in Korea. There are several important...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imaging in Tumor Immunology

Kim E, Youn H, Kang K

Recent advances in immune modulation have made impressive progress in cancer immunotherapy. Because dynamic nature of the immune response often makes it difficult to evaluate therapeutic outcomes, innovative imaging technologies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
KSNM60 in Non-thyroidal Radionuclide Therapy: Leaping into the Future

Byun B, Kim M, Han YH, Jeong HJ

This year, the Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary. Treatment, as well as diagnosis, has played a very important role in the development of nuclear...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radioguided Surgery in Insulinoma Using 68Ga Labeled Exendin-4: a Case Report

Das S, Thakral P, Manda D, CB V, Malik D, Sen I

Laparoscopic resection of tumor is often performed for benign and small insulinomas, or for those located in the body or tail of the pancreas. The precise preoperative and intraoperative localization...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Simulating dose reduction for myocardial perfusion SPECT using a Poisson resampling method

Kim IH, Lee S, An YS, Choi SY, Yoon JK

Purpose The purpose of this study was to determine the lowest Tl-201 dose that does not reduce the image quality of myocardial perfusion SPECT (MPS) by Poisson resampling simulation. Methods One...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multifocal Meningiomas Mimicking Metastasis on 18F-Fluciclovine PET/CT

Aldine A, Balaawi K, Saadeddin A, Shariftabrizi A, Kandemirl S

A 65-year-old male patient with a past medical history of prostate adenocarcinoma presented with biochemical recurrence (prostate-specific antigen level of 5.91 mg/L). 18F-FACBC PET/CT was acquired to evaluate the disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
68Ga-FAPI-46 PET/MR Detects Recurrent Cholangiocarcinoma and Intraductal Papillary Mucinous Neoplasm in a Patient Showing Increasing CEA with Negative 18F-FDG PET/CT and Conventional CT

Siripongsatian D, Promteangtrong C, Kunawudhi A, Kiatkittikul P, Chotipanich C

A patient with intrahepatic cholangiocarcinoma who underwent hepatic resection with completed neoadjuvant chemotherapy presented with increased CEA levels. Previous whole abdominal and chest CT scan revealed no evidence of local...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617

Mahmoudi E, Pirayesh E, Deevband M, Amoui M, Ghorbani Rad M, Ghorbani M

Purpose 177Lu-DKFZ-PSMA-617 is a promising treatment for patients with metastatic prostate cancer. Specific dosimetry for each patient is an important factor in planning the patient’s treatment process. This study aimed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr